Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04586244
Title An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma (Optimus)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Indications

invasive bladder transitional cell carcinoma

transitional cell carcinoma

Therapies

Retifanlimab

Epacadostat + Retifanlimab

Epacadostat

Age Groups: adult | senior
Covered Countries USA | ITA | FRA


No variant requirements are available.